The global mild cognitive impairment nutrition market is projected to reach USD 420.1 million in 2026 and USD 1,150.4 million by 2036, expanding at a CAGR of 10.6% during the forecast period. Market expansion is increasingly tied to whether manufacturers can substantiate clinical benefits for defined target populations while navigating strict regional regulations governing medical foods versus...